Related Experiment Video
Updated: Feb 23, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
Quantitative Phosphoproteomic Analysis Reveals Key Mechanisms of Cellular Proliferation in Liver Cancer Cells
Bo Zhu1, Quanze He2, Jingjing Xiang2
1State Key Laboratory of Genetic Engineering, Department of Genetics, School of Life Sciences, Fudan University, Shanghai, P.R. China.
Abstract:
Understanding the mechanisms of uncontrolled proliferation in cancer cells provides valuable insights into tumor development and is benefit for discovering efficient methods in cancer treatment. In this study, we identified and quantified 2,057 phosphoproteins and 9,824 unique phosphosites in three liver cell lines with high (QGY, Hep3B) and low (L02) proliferative potentials and disclosed the wide variations in phosphorylation sites and levels among them. We found that the number of identified phosphoproteins and phosphosites in these cells were negatively correlated with their proliferative abilities. The function analysis suggested that the aberrant phosphorylation of SR proteins and activation of MAPK pathway might be two critical factors to promote cancer cell proliferation. Meanwhile, the phosphorylation status of mini-chromosome maintenance (MCM) and nuclear pore (NPC) complexes are significantly different between cell lines with high and low proliferative potentials. Furthermore, the phosphosites targeted by kinase families of CDK, STE and HIPK in the proteins coded by cancer driver genes showed distinct profiles between caner and normal cell lines. These results present key phosphorylation networks involving in abnormal proliferation of cancer cells and uncovered potential molecular markers for estimating the proliferation ability of liver cancer cells.
Insights
Cancer cell proliferation is linked to specific protein phosphorylation patterns. This study identified key phosphorylation networks and potential biomarkers for liver cancer progression, aiding in developing new treatments.
Area of Science:
- Proteomics
- Cancer Biology
- Molecular Oncology
Background:
- Uncontrolled cancer cell proliferation is a hallmark of tumor development.
- Understanding the molecular mechanisms driving proliferation is crucial for effective cancer treatment strategies.
Purpose of the Study:
- To identify and quantify phosphoproteins and phosphosites in liver cell lines with varying proliferative potentials.
- To elucidate the role of specific phosphorylation events in regulating cancer cell proliferation.
- To uncover potential molecular markers for assessing liver cancer proliferation.
Main Methods:
- Quantitative phosphoproteomics was employed to analyze three liver cell lines (QGY, Hep3B, L02) with differing proliferative capacities.
- Bioinformatic analysis was used to identify differentially phosphorylated proteins and sites.
- Functional enrichment analysis was performed to determine the biological pathways affected by aberrant phosphorylation.
Main Results:
- A total of 2,057 phosphoproteins and 9,824 unique phosphosites were identified, with numbers negatively correlated to proliferative potential.
- Aberrant phosphorylation of SR proteins and activation of the MAPK pathway were implicated in promoting cancer cell proliferation.
- Significant differences in the phosphorylation status of mini-chromosome maintenance (MCM) and nuclear pore (NPC) complexes were observed between high and low proliferative cells.
- Distinct phosphorylation profiles were found for proteins encoded by cancer driver genes, targeted by kinase families (CDK, STE, HIPK), between cancer and normal cells.
Conclusions:
- Key phosphorylation networks involved in abnormal cancer cell proliferation were identified.
- Specific phosphosites and proteins may serve as valuable molecular markers for estimating liver cancer cell proliferation.
- These findings offer insights into novel therapeutic targets for liver cancer treatment.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

